港股異動丨建滔積層板大漲近7% 獲主席連續兩日增持149.6萬股
格隆匯11月1日丨建滔積層板(1888.HK)大漲近7%,報7.7港元,成交1.06億港元,總市值237億港元。

港交所權益資料顯示,建滔積層板獲主席及執行董事張國華於10月30日、31日在場內以每股平均價7.072港元、7.077港元分別增持123.6萬股及26萬股,兩日合計增持149.6萬股,共涉資約1058.1萬港元。增持後,張國華的最新持股數目為12,904,000股,最新持股比例由0.37%升至0.41%。中國移動、中國聯通、中國電信於今日正式上線5G商用套餐,這標誌着我國將正式進入5G商用時代。年初時,主席張國華表示,為迎接5G盛宴,公司今年的總產能將擴產10%~15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.